🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the pharmacokinetics, relative bioavailability, immu...
Status
Completed
Location
Altasciences Clinical Los Angeles /ID# 276446
Start Date
2025-05-08
Trial ID
NCT06946524
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety, pharmacokinet...
Status
Completed
Location
Renstar Medical Research
Start Date
2017-02-28
Trial ID
NCT02905331
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested
JS002 is a recombinant humanized anti-PCSK9 monoclonal antibody. This is a ...
Status
Completed
Location
Beijing Anzhen Hospital，Capital Medical University
Start Date
2022-02-28
Trial ID
NCT05532800
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
Thrive Health - Beverly Hills
Start Date
2024-03-27
Trial ID
NCT06307613
Treatments Being Tested
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The primary objective of this study is to is to assess the ability of retin...
Status
Completed
Location
Retina Consultants of Texas - Austin Retina
Start Date
2023-01-23
Trial ID
NCT05704725
Treatments Being Tested
The primary objective is to demonstrate that the auto-injector(AI) is suita...
Status
Completed
Location
Regeneron Research Facility
Start Date
2019-01-23
Trial ID
NCT03491904
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetic (PK) profi...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01610310
Prospective, randomized and open label trial Hypothesis * Infusion of int...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2009-11
Trial ID
NCT01538771
Treatments Being Tested